Patents by Inventor David Moe
David Moe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190282041Abstract: A sink unit with hand drying assembly including a casement having a top element, a front and a back, a basin having a rim, carried by the casement with the rim adjacent the top element. A faucet is carried by the casement intermediate the basin and the back. a nozzle fixture is carried by the top proximate the rim and includes a housing having a nozzle, and a base with an aperture formed therethrough. An anchor post extends downwardly from the base to a position below the top element. The anchor post defines an air passage therethrough, the air passage aligned with and coupled in communication with the aperture. A fastener engages the anchor post, securing the nozzle fixture to the top element adjacent the basin. A channel element defines a channel coupling the aperture to the nozzle.Type: ApplicationFiled: March 14, 2018Publication date: September 19, 2019Inventor: David Moe
-
Publication number: 20150376881Abstract: A vanity unit with hand dryer includes a casement having a top, a front and a back. A basin having a rim is carried by the casement with the rim adjacent the top. A space is defined below the casement top and the basin, and an aperture is formed proximate the rim of the basin toward the front of the casement in communication with the space below the top and the basin. A faucet is carried by the casement intermediate the basin and the back, and a hand drying assembly supplies air through the aperture from the space.Type: ApplicationFiled: June 12, 2015Publication date: December 31, 2015Inventor: David Moe
-
Patent number: 8298823Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system.Type: GrantFiled: March 24, 2010Date of Patent: October 30, 2012Assignee: Sanofi Pasteur Vaxdesign CorporationInventors: William L. Warren, Robert Parkhill, Michael N. Nguyen, Guzman Sanchez-Schmitz, Heather Fahlenkamp, Russell Higbee, Donald Drake, III, Anatoly Kachurin, David Moe
-
Patent number: 8274358Abstract: A multidirectional input member according to the present invention includes a base plate on which a looped sensor that includes a plurality of groups of non-contacting electrodes configured in a loop is formed and an operation plate locating opposite to the base plate. The operation plate has a first loop-shaped protrusion that is located at a plane opposite to the base plate, that is protruded toward the base plate side, that is opposite to the looped sensor, and that is configured with a resistant rubber member. The first protrusion has a configuration in which its sectional area of a plane parallel to the base plate is tapered in the direction from the operation plate side toward the base plate side.Type: GrantFiled: June 18, 2010Date of Patent: September 25, 2012Assignee: Shin-Etsu Polymer Co., Ltd.Inventors: Hitoshi Ando, Brian St. Jacques, David Moe
-
Publication number: 20110309908Abstract: A multidirectional input member according to the present invention includes a base plate on which a looped sensor that includes a plurality of groups of non-contacting electrodes configured in a loop is formed and an operation plate locating opposite to the base plate. The operation plate has a first loop-shaped protrusion that is located at a plane opposite to the base plate, that is protruded toward the base plate side, that is opposite to the looped sensor, and that is configured with a resistant rubber member. The first protrusion has a configuration in which its sectional area of a plane parallel to the base plate is tapered in the direction from the operation plate side toward the base plate side.Type: ApplicationFiled: June 18, 2010Publication date: December 22, 2011Applicant: Shin-Etsu Polymer Co., Ltd.Inventors: Hitoshi Ando, Brian St. Jacques, David Moe
-
Patent number: 7785883Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system.Type: GrantFiled: March 15, 2006Date of Patent: August 31, 2010Assignee: Vax Design Corp.Inventors: William L. Warren, Robert Parkhill, Michael N. Nguyen, Guzman Sanchez-Schmitz, Heather Fahlenkamp, Russell Higbee, Donald Drake, III, Anatoly Kachurin, David Moe
-
Publication number: 20100178676Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system.Type: ApplicationFiled: March 24, 2010Publication date: July 15, 2010Applicant: VAXDESIGN CORP.Inventors: William L. WARREN, Robert PARKHILL, Michael N. NGUYEN, Guzman SANCHEZ-SCHMITZ, Heather FAHLENKAMP, Russell HIGBEE, Donald DRAKE, III, Anatoly KACHURIN, David MOE
-
Publication number: 20100105135Abstract: Dendritic cells (DCs) for research and clinical applications are typically derived from purified blood monocytes that are cultured in a cocktail of cytokines for a week or more. Because it has been suggested that these cytokine-derived DCs may be deficient in some important immunological functions and might not accurately represent antigen-presenting cell (APC) populations found under physiologic conditions, there is a need for methods that allow the generation of DCs in a more physiologically relevant manner. The present invention comprises a simple and reliable technique for generating large numbers of highly purified DCs, based on a single migration of blood monocytes through endothelial cells that are cultured in, for example, a Transwell® device.Type: ApplicationFiled: October 30, 2009Publication date: April 29, 2010Applicant: VaxDesign Corp.Inventors: Donald DRAKE, III, David MOE, Conan LI, Heather FAHLENKAMP, Guzman SANCHEZ-SCHMITZ, Russell HIGBEE, Robert PARKHILL, William L. WARREN
-
Publication number: 20070178076Abstract: Dendritic cells (DCs) for research and clinical applications are typically derived from purified blood monocytes that are cultured in a cocktail of cytokines for a week or more. Because it has been suggested that these cytokine-derived DCs may be deficient in some important immunological functions and might not accurately represent antigen-presenting cell (APC) populations found under physiologic conditions, there is a need for methods that allow the generation of DCs in a more physiologically relevant manner. The present invention comprises a simple and reliable technique for generating large numbers of highly purified DCs, based on a single migration of blood monocytes through endothelial cells that are cultured in, for example, a Transwell® device.Type: ApplicationFiled: December 21, 2006Publication date: August 2, 2007Inventors: Donald Drake, David Moe, Conan Li, Heather Fahlenkamp, Guzman Sanchez-Schmitz, Russell Higbee, Robert Parkhill, William Warren
-
Publication number: 20070141552Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system.Type: ApplicationFiled: November 8, 2006Publication date: June 21, 2007Inventors: William Warren, Robert Parkhill, Michael Nguyen, Guzman Sanchez-Schmitz, Heather Fahlenkamp, Russell Higbee, Donald Drake, Anatoly Kachurin, David Moe
-
Publication number: 20060270029Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system.Type: ApplicationFiled: March 15, 2006Publication date: November 30, 2006Inventors: William Warren, Robert Parkhill, Michael Nguyen, Guzman Sanchez-Schmitz, Heather Fahlenkamp, Russell Higbee, Donald Drake, Anatoly Kachurin, David Moe
-
Patent number: 7047582Abstract: The present invention relates to stain removal methods and products associated therewith. The methods of the present invention are especially useful as part of a dry cleaning operation, but can also be used under any circumstances where stain removal from articles, especially fabrics, is desired.Type: GrantFiled: March 19, 2002Date of Patent: May 23, 2006Assignee: The Procter & Gamble CompanyInventors: Kevin David Moe, Shellie Jean Caudill, Janice Quintana Sadlowski
-
Patent number: 6830591Abstract: A method for the treatment of a non-finished textile component is provided. The method comprises the steps of treating a non-finished textile component in an aqueous bleaching solution of hydrogen and a hydrophobic bleach activator or hydrophobic peracid. Preferred bleach activators include the alkanoyloxybenzene sulfonates and in particular noanoyloxybenzene sulfonate. The method provides superior fiber protection and fabric strength benefits versus conventional processing as well as significant savings in both energy and time due to the lower bleaching temperatures.Type: GrantFiled: February 15, 2001Date of Patent: December 14, 2004Assignee: The Procter & Gamble CompanyInventors: Jiping Wang, Nodie Monroe Washington, Kevin David Moe
-
Publication number: 20030028974Abstract: The present invention relates to stain removal methods and products associated therewith. The methods of the present invention are especially useful as part of a dry cleaning operation, but can also be used under any circumstances where stain removal from articles, especially fabrics, is desired.Type: ApplicationFiled: March 19, 2002Publication date: February 13, 2003Inventors: Kevin David Moe, Shellie Jean Caudill, Janice Quintana Sadlowski